Drugs Made In America Acquisition Corp
DMAA ✗ NOT COMPLIANTFree checks used up today ☆ Track — members
NASDAQ
·
Financials
·
Investment Holding Companies
·
Last Close
$10.88
▲ +0.14%
Price charts are for members
Interactive price history from intraday to 5 years, on every stock and ETF.
See plans
Key Metrics
P/E Ratio
51.89
FWD: N/A
Market Cap
$524.44M
Small Cap
Div Yield
N/A
N/A
EPS Growth
N/A
YoY
RSI (14)
50.00
Momentum
Beta
N/A
vs Market
52W High
$10.90
0.32% below
52W Low
$10.30
5.59% above
Volume
1.20K
Avg 5.86K
P/B
1.50
Price-to-book
ROE
N/A
Return on equity
Free Float
76.43%
Public shares
Historical Returns
5D
+0.28%
1M
+0.28%
3M
+1.97%
6M
+3.23%
YTD
+4.92%
1Y
+5.68%
3Y
N/A
5Y
N/A
Financials & Valuation
TTM · Annual
| Total Revenue | $0.00 |
| Net Income | $5.94M |
| Revenue Growth (YoY) | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Profit Margin | N/A |
| ROE | N/A |
| ROA · ROIC | 4.94% · N/A |
| P/E Ratio | 51.89 |
| Forward P/E (FY1) | N/A |
| PEG Ratio | 0.06 |
| P/S | N/A |
| P/B | 1.50 |
| P/FCF | N/A |
| EPS Growth | N/A |
| Outstanding Shares | 24.28M |
Technical Indicators
| 50-Day SMA | $10.81 |
| 200-Day SMA | $10.62 |
| RSI (14) | 50.00 |
| Beta | N/A |
| 52-Week High | $10.90 |
| 52-Week Low | $10.30 |
| Volume Today | 1.20K |
| Avg Daily Volume (30D) | 5.86K |
| Relative Volume | 0.20x |
| Volatility (10D) | 2.50 |
| Volatility (30D) | 3.19 |
| Free Float | 76.43% |
